Last updated: April 23, 2026
Which companies supply dexamethasone as an API?
Dexmethasone is manufactured and supplied by multiple global API and intermediates players. Supplier lists vary by form (API vs intermediate), grade (USP/EP), and regulatory status (DMF/CEP availability). The companies below are commonly cited in trade and regulatory contexts as dexamethasone API suppliers.
Commonly listed dexamethasone API suppliers (selected):
| Supplier |
Typical role in market |
Notes you typically see in procurement |
| Zhejiang Hisun Pharmaceutical Co., Ltd. |
API and generics manufacturer |
China-based manufacturer with broad steroid capability coverage |
| Hikma Pharmaceuticals |
Brand and generic manufacturer; may include API supply chains |
Frequently appears across global generic steroid portfolios |
| Cipla Ltd. |
Generics manufacturer |
Often supplies finished-dosage versions; may be linked to API sourcing in procurement chains |
| Dr. Reddy’s Laboratories |
Generics and active manufacture |
Frequently supplies finished dosage; API chain availability depends on product |
| Sandoz (Novartis) |
Generics manufacturer |
Finished dosage supply and contract manufacturing footprint |
| Teva |
Generics and operations across supply chain |
Finished dosage supply; API procurement depends on site and filing |
| Mylan (now Viatris) |
Generics |
Finished dosage supply; API sourcing depends on product and filing |
Who supplies dexamethasone finished dosage forms (tablets, injections)?
Finished dosage supply is broader than API supply because the commercial market is dominated by generics and local distributors. The suppliers below commonly appear as manufacturers or marketing authorizations for dexamethasone tablets and injectable products.
Common dexamethasone finished dosage suppliers (selected):
| Supplier |
Finished-dosage footprint |
Typical forms in market |
| Pfizer |
Brand history and legacy markets |
Tablets and injectable lines depending on country |
| Merck KGaA (EMD Serono/legacy ecosystems) |
Presence through authorization networks |
Tablets/injections by region |
| Sandoz |
Generic supply |
Tablets and injections |
| Teva |
Generic supply |
Tablets and injections |
| Viatris |
Generic supply |
Tablets and injections |
| Cipla |
Generic supply |
Tablets and injections |
| Dr. Reddy’s |
Generic supply |
Tablets and injections |
| Hikma |
Generic supply |
Tablets and injections |
Which suppliers are strongest for injection-grade dexamethasone?
Injection-grade dexamethasone has tighter process, container closure, and sterile-manufacturing controls. In practice, the best-qualified suppliers are the ones with established sterile injectable manufacturing capacity and validated stability packages, which typically track to larger generics manufacturers.
Sterile injection commonly points to these suppliers:
- Sandoz
- Teva
- Viatris
- Dr. Reddy’s Laboratories
- Hikma
- Cipla
- Pfizer (legacy/region dependent)
What procurement categories should you treat dexamethasone sourcing as?
Dexamethasone sourcing usually splits into three procurement categories, each with different supplier lists:
- API (dexamethasone)
- Typically supplied by API manufacturers and specialty steroid producers.
- Intermediates (if you are contracting chemistry)
- Supplier set differs from API and depends on the synthetic route and DMF strategy.
- Finished dosage (tablets and injection)
- Dominated by global generics manufacturers and regional marketing authorization holders.
How to filter suppliers for regulatory readiness
When you buy dexamethasone API or finished products, the supplier list narrows by what the buyer actually needs:
- Documentation availability: DMF/CEP and latest audit readiness for the manufacturing site
- Grade alignment: USP/EP/BP specification match
- Sterile manufacturing capability (for injections): validated aseptic process and packaging controls
- Batch traceability: lot-level CoA support and complaint history access
- Supply continuity: allocation risk and lead-time stability for the specific strength and packaging
Market reality: why supplier lists differ by form
Dexamethasone is an established steroid with mature supply chains, so supplier counts are high at the finished-dose level. API supply can still be concentrated by grade and compliance status, and injection form qualification often further concentrates supplier choices to sterile-capable manufacturers.
Key Takeaways
- Dexamethasone sourcing splits into API, intermediates, and finished dosage, and supplier lists change materially by category.
- Global generics manufacturers (Sandoz, Teva, Viatris, Dr. Reddy’s, Hikma, Cipla) dominate finished-dose supply.
- API sourcing tends to include major steroid-capable API manufacturers (including China-based producers such as Zhejiang Hisun) with filings and grades that align to buyer requirements.
- For injection, selection concentrates around suppliers with established sterile manufacturing and stable packaging/validation packages.
FAQs
1) Are dexamethasone API suppliers the same as finished-dose manufacturers?
No. API supply and finished-dose manufacturing often use different supplier bases, even when the same company group is present across the supply chain.
2) Which form matters most for supplier shortlisting?
Injection-grade products typically drive tighter qualification and narrow the supplier set versus tablets.
3) Does dexamethasone sourcing depend on DMF or CEP availability?
Yes. Buyers typically filter suppliers by submission readiness (DMF/CEP) and manufacturing site documentation.
4) Are China-based API manufacturers a major part of dexamethasone supply?
Yes. The API market includes major China-based steroid and API producers; regulatory and grade alignment still determines which suppliers pass procurement screens.
5) How do lead times differ for API vs finished dosage?
Finished dosages usually have more stable commercial lead times from qualified generics suppliers, while API timing can depend on site capacity, grade, and filing-specific batches.
References
[1] EMA. European Medicines Agency. Public assessment reports and product information (accessed via EMA Medicines). https://www.ema.europa.eu/
[2] FDA. U.S. Food and Drug Administration. Drug approvals and database resources for dexamethasone products (accessed via Drugs@FDA). https://www.accessdata.fda.gov/scripts/cder/daf/
[3] WHO. World Health Organization. Medicines and regulatory guidance resources (accessed via WHO portals). https://www.who.int/
